Showing results (271-280 of 298) with videos related to
Sort By:
Pageof 30
Nature Neuroscience|November 11, 2024
Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer's diseaseAlberto Serrano-Pozo, Huan Li, Zhaozhi Li, et al.Acta Neuropathologica|April 1, 2024
Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer's disease reveals distinct sequential responses to Aβ and tauAstrid Wachter, Maya E Woodbury, Sylvia Lombardo, et al.Plos One|March 6, 2014
Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern ChinaHong Ji, Qin Gu, Li-Ling Chen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.Acta Neuropathologica Communications|May 19, 2025
hiPSC-neurons recapitulate the subtype-specific cell intrinsic nature of susceptibility to neurodegenerative disease-relevant aggregationIan Weidling, Christina N Preiss, Sarah E Chancellor, et al.Eclinicalmedicine|May 27, 2024
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 studyZhihao Lu, Li Kong, Buhai Wang, et al.BMC Cancer|December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter studyXinlong Zheng, Longfeng Zhang, Lin Wu, et al.The Lancet. Oncology|December 9, 2024
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective studyYu Zhao, Shan Xiong, Qin Ren, et al.Therapeutic Advances in Medical Oncology|July 24, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populationsJun Wang, Bicheng Zhang, Ling Peng, et al.Therapeutic Advances in Medical Oncology|August 7, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysisQiaofeng Zhong, Longfeng Zhang, Lin Wu, et al.Pageof 30